XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 0.87%7.26B | -27.63%14.49B | -28.83%7.2B | 26.41%20.03B | 56.29%10.11B | 57.74%15.84B | 39.57%6.47B | -22.49%10.04B | -23.33%4.64B | -8.86%12.96B |
Operating income | 0.87%7.26B | -27.63%14.49B | -28.83%7.2B | 26.41%20.03B | 56.29%10.11B | 57.74%15.84B | 39.57%6.47B | -22.49%10.04B | -23.33%4.64B | -8.86%12.96B |
Cost of sales | 4.03%-5.82B | 10.78%-12.06B | 5.01%-6.07B | -27.17%-13.51B | -33.73%-6.39B | -36.24%-10.63B | -31.55%-4.78B | 18.01%-7.8B | 16.26%-3.63B | 1.80%-9.51B |
Operating expenses | 4.03%-5.82B | 10.78%-12.06B | 5.01%-6.07B | -27.17%-13.51B | -33.73%-6.39B | -36.24%-10.63B | -31.55%-4.78B | 18.01%-7.8B | 16.26%-3.63B | 1.80%-9.51B |
Gross profit | 27.16%1.44B | -62.60%2.44B | -69.62%1.13B | 24.85%6.51B | 119.82%3.73B | 132.45%5.22B | 68.50%1.7B | -34.86%2.24B | -41.22%1.01B | -23.96%3.45B |
Selling expenses | 9.32%-230.16M | -0.86%-503.04M | -16.29%-253.8M | -48.24%-498.77M | -14.09%-218.25M | 4.87%-336.45M | -12.32%-191.3M | 3.43%-353.68M | 5.94%-170.31M | -2.10%-366.26M |
Administrative expenses | -53.69%-344.37M | 34.86%-647.29M | 60.56%-224.07M | -8.81%-993.74M | -129.72%-568.19M | -155.93%-913.26M | -25.77%-247.34M | 46.59%-356.85M | 36.25%-196.66M | 14.64%-668.11M |
Research and development expenses | 32.46%-321.44M | 28.65%-935.1M | 22.81%-475.93M | -56.22%-1.31B | -103.66%-616.59M | -42.07%-838.89M | -51.08%-302.76M | -79.34%-590.47M | -40.13%-200.4M | -85.63%-329.24M |
Profit from asset sales | --38.83M | ---- | ---- | 4,528.13%1.21B | ---- | -167.02%-27.38M | ---- | --40.85M | --40.85M | ---- |
Revaluation surplus | ---- | ---- | ---- | -272.24%-37.67M | -431.15%-37.67M | 649.77%21.87M | -521.02%-7.09M | ---3.98M | ---1.14M | ---- |
-Changes in the fair value of financial assets | ---- | ---- | ---- | -272.24%-37.67M | -431.15%-37.67M | 649.77%21.87M | -521.02%-7.09M | ---3.98M | ---1.14M | ---- |
Special items of operating profit | 3.95%97.52M | 17.53%269.16M | -1.75%93.82M | 25.81%229.01M | -0.84%95.49M | 33.64%182.03M | 12.53%96.3M | -1.67%136.21M | 81.78%85.58M | 16.20%138.52M |
Operating profit | 149.75%680.29M | -87.88%619.87M | -88.57%272.39M | 54.74%5.11B | 128.29%2.38B | 196.01%3.31B | 84.93%1.04B | -49.72%1.12B | -49.91%564.32M | -31.35%2.22B |
Financing cost | -41.57%-2.16M | 89.16%-1.66M | 91.11%-1.53M | 81.25%-15.3M | 67.48%-17.16M | 21.95%-81.61M | 13.34%-52.76M | -4.01%-104.56M | -11.46%-60.88M | ---100.53M |
Share of profits of associates | -131.06%-5.25M | 37.65%34.97M | 7.73%16.89M | 25.18%25.4M | 123.26%15.68M | 350.41%20.29M | 206.19%7.02M | --4.51M | --2.29M | ---- |
Earning before tax | 133.84%672.88M | -87.26%653.17M | -87.91%287.76M | 57.98%5.13B | 138.61%2.38B | 219.12%3.24B | 97.32%997.9M | -52.05%1.02B | -52.82%505.74M | -34.46%2.12B |
Tax | -248.46%-277.67M | 95.56%-42.09M | 80.73%-79.69M | -68.65%-948.94M | -103.55%-413.42M | -394.58%-562.66M | -244.31%-203.11M | 69.90%-113.77M | 51.70%-58.99M | 52.76%-378.02M |
After-tax profit from continuing operations | 89.94%395.21M | -85.37%611.09M | -89.43%208.07M | 55.74%4.18B | 147.57%1.97B | 197.01%2.68B | 77.91%794.79M | -48.18%902.86M | -52.96%446.75M | -28.44%1.74B |
Earning after tax | 89.94%395.21M | -85.37%611.09M | -89.43%208.07M | 55.74%4.18B | 147.57%1.97B | 197.01%2.68B | 77.91%794.79M | -48.18%902.86M | -52.96%446.75M | -28.44%1.74B |
Minority profit | 215.51%87.56M | -130.17%-96.71M | -127.58%-75.8M | -47.16%320.58M | 43.49%274.87M | 364.23%606.7M | 349.46%191.56M | -53.21%130.69M | -62.13%42.62M | -8.60%279.31M |
Profit attributable to shareholders | 8.38%307.65M | -81.64%707.79M | -83.23%283.87M | 85.82%3.86B | 180.62%1.69B | 168.70%2.07B | 49.27%603.23M | -47.22%772.17M | -51.73%404.13M | -31.29%1.46B |
Basic earnings per share | 30.77%0.17 | -81.50%0.32 | -82.89%0.13 | 76.53%1.73 | 162.07%0.76 | 164.86%0.98 | 45.00%0.29 | -47.14%0.37 | -50.00%0.2 | -30.00%0.7 |
Diluted earnings per share | 30.77%0.17 | -81.50%0.32 | -82.89%0.13 | 76.53%1.73 | 162.07%0.76 | 164.86%0.98 | 45.00%0.29 | -47.14%0.37 | -50.00%0.2 | -30.00%0.7 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.